
The Autumn Budget was announced and one of the few major announcements that had not been leaked prior to the …

Dear Colleague, Biopharmaceutical companies are increasingly partnering with a diverse set of health care stakeholders to address scientific and technological …

A team of researchers at Imperial College London (ICL) has argued that the proposal by US Congress to cut the …

In a 10-year study conducted at the Indiana University School of Medicine, researchers were able to observe a 29% reduced …

GlaxoSmithKline has announced that the FDA has awarded US marketing authorisation to the first two-drug regimen in the treatment of …

The EMA has given approval for the treatment of Orexo’s Zubsolv, a therapy for the treatment of opioid dependence. The …

In our latest free to attend webinar, we have joined up with NDA to bring you the latest market access …

Boehringer Ingelheim has unveiled opnME.com, a centralised platform which makes available selected pre-clinical molecules from its portfolio for free, accessible …

A study from Sweden’s Karolinska Institute has indicated that cancerous tumours in overweight women are likely to be larger and …

The Competition and Markets Authority (CMA) has pulled up Concordia as, provisionally, being found to have raised the price of …

In a decision that was likened to a penalty shoot-out, Amsterdam was announced as the winner of the race to …

Brian Woodfall, Global Head of Late Development, Infectious Diseases at Janssen, explains why a future without HIV can only be …

Acorda Therapeutics has announced that it is terminate development of its Parkinson’s therapy tozadenant after five deaths were reported as …

A new study from the American Academy of Pediatrics has found that, despite warnings from the FDA, doctors are still …

Roche has unveiled new Phase 3 efficacy data which showed strong findings for its immunotherapy Tecentriq (atezolizumab) in combination with …